WuXi Financial Statements From 2010 to 2024
| WXXWY Stock | USD 4.00 0.24 6.38% |
Check WuXi Biologics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among WuXi Biologics' main balance sheet or income statement drivers, such as , as well as many indicators such as . WuXi financial statements analysis is a perfect complement when working with WuXi Biologics Valuation or Volatility modules.
WuXi |
WuXi Biologics Company Shares Outstanding Analysis
WuXi Biologics' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current WuXi Biologics Shares Outstanding | 2.11 B |
Most of WuXi Biologics' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, WuXi Biologics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, WuXi Biologics has 2.11 B of shares currently outstending. This is much higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The shares outstanding for all United States stocks is significantly lower than that of the firm.
WuXi Biologics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining WuXi Biologics's current stock value. Our valuation model uses many indicators to compare WuXi Biologics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across WuXi Biologics competition to find correlations between indicators driving WuXi Biologics's intrinsic value. More Info.WuXi Biologics is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers reporting about 0.45 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for WuXi Biologics is roughly 2.23 . Comparative valuation analysis is a catch-all model that can be used if you cannot value WuXi Biologics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for WuXi Biologics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About WuXi Biologics Financial Statements
WuXi Biologics investors use historical fundamental indicators, such as WuXi Biologics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in WuXi Biologics. Please read more on our technical analysis and fundamental analysis pages.
WuXi Biologics Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the Peoples Republic of China, North America, Europe, and internationally. The company was incorporated in 2014 and is headquartered in Wuxi, China. Wuxi Biologics is traded on OTC Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for WuXi Pink Sheet Analysis
When running WuXi Biologics' price analysis, check to measure WuXi Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy WuXi Biologics is operating at the current time. Most of WuXi Biologics' value examination focuses on studying past and present price action to predict the probability of WuXi Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move WuXi Biologics' price. Additionally, you may evaluate how the addition of WuXi Biologics to your portfolios can decrease your overall portfolio volatility.